HomeAnalysisPharmaWhat’s driving pharma outsourcing in 2025 and beyond?

What’s driving pharma outsourcing in 2025 and beyond?

-

With ever-changing regulatory dynamics, technological innovation and scientific progress impacting drug development, navigating the pharmaceutical industry’s constant evolution is not easy.

Following the 2025 EPA Conference in Amsterdam, Europe’s largest conference for market access, pricing and evidence, ECI Partners look at five key trends – from new EU health regulations to AI-driven innovation.

Provide your email address to continue reading

For unlimited free access to all articles and analysis from the past month

Or to access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?
ECI Partners
ECI Partnershttps://www.ecipartners.com/
ECI Partners is a leading private equity investor, focussed on offering collaborative support to management teams. With funds under management exceeding £2 billion, ECI invests in growth businesses, targeting companies valued up to £300 million. ECI’s collaborative approach has been the foundation of their exceptional results for over 45 years. Previous successful HealthTech investments for ECI include Clinisys, Harmoni and Ascribe, and most recently 4ways (delivering 2.7x return on exit).
Related Articles
More From Author

…

Provide your email address to continue reading

For unlimited free access to all articles and analysis from the past month

Or to access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?

…

Provide your email address to continue reading

For unlimited free access to all articles and analysis from the past month

Or to access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?
Advertisement

Related Resources

Related Events